tiprankstipranks
Trending News
More News >
Galaxy Surfactants Ltd. (IN:GALAXYSURF)
:GALAXYSURF
India Market
Advertisement

Galaxy Surfactants Ltd. (GALAXYSURF) AI Stock Analysis

Compare
0 Followers

Top Page

IN:GALAXYSURF

Galaxy Surfactants Ltd.

(GALAXYSURF)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
₹2,633.00
▲(20.87% Upside)
Galaxy Surfactants Ltd. has a strong financial foundation with consistent growth and stability, which is the most significant factor in its stock score. Technical indicators suggest some short-term uncertainty, and the valuation indicates moderate pricing. The absence of earnings call and corporate events data limits additional insights.

Galaxy Surfactants Ltd. (GALAXYSURF) vs. iShares MSCI India ETF (INDA)

Galaxy Surfactants Ltd. Business Overview & Revenue Model

Company DescriptionGalaxy Surfactants Limited manufactures and markets specialty chemicals for personal and home care industries in India and internationally. The company offers fatty alcohol surfactants, fatty alcohol ethoxylates, alkyl benzene sulphonic acids, foam and viscosity boosters, mild surfactants, pearlizers, surfactant blends, syndet and TBB, sunscreens, preservatives, and blends, as well as emollients, conditioning agents, hair color protector, scalp care, and anti-microbials. It serves the skin, hair, sun, oral, baby, and home care markets. The company was founded in 1980 and is based in Navi Mumbai, India.
How the Company Makes MoneyGalaxy Surfactants Ltd. generates revenue primarily through the sale of its surfactants and specialty chemicals to the personal and home care sectors. The company's key revenue streams include the production and distribution of performance surfactants, which are used as key ingredients in formulations for shampoos, body washes, and other personal care products. Additionally, the company earns income from its range of specialty chemicals, which enhance the performance, texture, and stability of consumer products. Galaxy Surfactants' revenue model is bolstered by its long-term partnerships with leading consumer goods companies, its focus on innovation and sustainability, and its ability to cater to diverse market needs across various geographies.

Galaxy Surfactants Ltd. Financial Statement Overview

Summary
Galaxy Surfactants Ltd. demonstrates strong financial health with consistent revenue and profit growth, prudent financial leverage, and robust cash flow management. The company is well-positioned within the specialty chemicals industry, though continuous monitoring of cash flow trends is crucial.
Income Statement
85
Very Positive
Galaxy Surfactants Ltd. has shown consistent revenue growth, with a notable increase in total revenue from 2024 to 2025. The gross profit and net profit margins are strong, indicating efficient cost management and profitability. EBIT and EBITDA margins are healthy, supporting a robust operating performance.
Balance Sheet
78
Positive
The company maintains a solid equity base, with a strong equity ratio indicating financial stability. The debt-to-equity ratio is low, suggesting conservative leverage. The return on equity is favorable, reflecting effective utilization of shareholder funds. Overall, the balance sheet is stable with a healthy equity position.
Cash Flow
80
Positive
Operating cash flows are strong, with a positive free cash flow trajectory. The free cash flow to net income ratio is favorable, indicating efficient cash management. However, a slight decline in free cash flow growth in the past year suggests areas needing attention.
BreakdownTTMDec 2025Dec 2024Dec 2022Dec 2022Dec 2020
Income Statement
Total Revenue42.24B42.24B37.65B36.53B44.45B25.63B
Gross Profit13.38B13.38B11.58B10.44B13.16B5.27B
EBITDA5.02B4.84B4.98B4.13B5.75B3.73B
Net Income3.05B3.05B3.01B2.63B3.81B2.30B
Balance Sheet
Total Assets34.62B34.62B29.15B26.01B27.34B18.12B
Cash, Cash Equivalents and Short-Term Investments5.14B5.14B4.38B692.40M2.47B477.80M
Total Debt2.10B2.10B1.87B4.21B3.27B3.96B
Total Liabilities11.00B11.00B7.35B10.26B8.52B7.44B
Stockholders Equity23.63B23.63B21.79B15.74B18.83B10.68B
Cash Flow
Free Cash Flow0.002.37B3.60B-1.50B4.27B1.74B
Operating Cash Flow0.004.21B5.18B49.30M5.73B3.16B
Investing Cash Flow0.00-2.95B-3.44B-841.20M-1.49B-1.51B
Financing Cash Flow0.00-1.57B-1.89B591.50M-2.64B-1.44B

Galaxy Surfactants Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2178.35
Price Trends
50DMA
2400.40
Negative
100DMA
2404.01
Negative
200DMA
2362.27
Negative
Market Momentum
MACD
-28.26
Positive
RSI
30.55
Neutral
STOCH
6.43
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GALAXYSURF, the sentiment is Negative. The current price of 2178.35 is below the 20-day moving average (MA) of 2338.21, below the 50-day MA of 2400.40, and below the 200-day MA of 2362.27, indicating a bearish trend. The MACD of -28.26 indicates Positive momentum. The RSI at 30.55 is Neutral, neither overbought nor oversold. The STOCH value of 6.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GALAXYSURF.

Galaxy Surfactants Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
104.17B34.6658.21%2.94%2.37%23.22%
74
Outperform
₹77.23B25.351.01%18.32%-0.43%
73
Outperform
153.21B46.846.12%0.25%10.63%7.53%
68
Neutral
114.09B31.2218.07%1.12%1.59%-2.52%
64
Neutral
84.00B58.5623.88%0.04%93.55%240.14%
50
Neutral
92.63B125.516.16%4.91%-55.92%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:GALAXYSURF
Galaxy Surfactants Ltd.
2,178.35
-772.47
-26.18%
IN:HONASA
Honasa Consumer Limited
284.70
-173.85
-37.91%
IN:JYOTHYLAB
Jyothy Labs Limited
310.70
-240.84
-43.67%
IN:MANORAMA
Manorama Industries Ltd.
1,406.80
576.65
69.46%
IN:PGHL
Procter & Gamble Health Ltd.
6,275.75
1,027.93
19.59%
IN:ZYDUSWELL
Zydus Wellness Limited
481.55
79.97
19.91%

Galaxy Surfactants Ltd. Corporate Events

Galaxy Surfactants Announces Board Transition
Sep 8, 2025

Galaxy Surfactants Ltd. announced the cessation of Mrs. Nandita Gurjar as a Non-Executive Independent Director, effective September 8, 2025, due to the completion of her tenure. The company expressed gratitude for her contributions, indicating a routine transition in its board structure, which is not expected to impact its operations significantly.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 23, 2025